Furthermore, findings have shown that Alb and BCHE levels are associated with sarcopenia,25,26 which is significantly associated with impaired OS and a high risk of tumor recurrence for patients with HCC.27 These findings strongly suggest that this marker reflects patients’ overall condition and comorbidities. Here, BCHE is linked to hepatocellular carcinoma.